Agenus Inc. (Nasdaq: AGEN) has acquired biopharmaceutical company 4-Antibody AG. 

The target develops the Retrocyte Display technology platform, which aims to help regulate immune response to cancers and other diseases.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.